General Information of the Compound
| Compound ID |
CP0411311
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[4-ethoxy-3-(5-methyl-4-oxo-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-2-yl)phenyl]-N-hydroxybenzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C24H25N5O4
|
||||||||||||||||||
| Molecular Weight |
447.495
|
||||||||||||||||||
| Canonical SMILES |
CCCc1nc(C)c2n1nc([nH]c2=O)-c1cc(ccc1OCC)-c1ccc(cc1)C(=O)NO
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C24H25N5O4/c1-4-6-20-25-14(3)21-24(31)26-22(27-29(20)21)18-13-17(11-12-19(18)33-5-2)15-7-9-16(10-8-15)23(30)28-32/h7-13,32H,4-6H2,1-3H3,(H,28,30)(H,26,27,31)
Show/Hide
|
||||||||||||||||||
| InChIKey |
OQSYENMWQGYXMW-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01176, cGMP-specific 3',5'-cyclic phosphodiesterase
Protein ID: PT00991, Histone deacetylase 1
Protein ID: PT00835, Histone deacetylase 2
Protein ID: PT01213, Histone deacetylase 6